RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAUDA R
Collezione ASL Città di Torino

Items : 9

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Gori A; Antinori A; Vergori A; Cossu MV; Menzaghi B; Sterrantino G; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

2018
ASL Città di Torino

Fabbiani M; Gagliardini R; Ciccarelli N; Quiros Roldan E; Latini A; d'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Del Pin B; Lombardi F; D'Avino A; Focà E; Colafigli M; Cauda R; Di Giambenedetto S; De Luca A;

Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2018 Feb;51(2):244-248. doi: 10.1016/j.ijantimicag.2017.08.019. Epub 2017 A

2018
ASL Città di Torino

Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;

Treatment simplification to atazanavir/ritonavir?+?lamivudine versus maintenance of atazanavir/ritonavir?+?two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557.

2017
ASL Città di Torino

Di Giambenedetto S; Fabbiani M; Quiros Roldan E; Latini A; D'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Di Pietro M; Mondi A; Ciccarelli N; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Jul;70(7):2133-43. doi: 10.1093/jac/dkv086. Epub 2015 Apr 21.

2015
ASL Città di Torino

Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. doi: 10.1016/j.cmi.2015.08.001. Epub 2015 Aug 14.

2015
ASL Città di Torino

Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;

Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jun;58(6):3514-20. doi: 10.1128/AAC.02373-13. Epub 2014 Apr 14.

2014
ASL Città di Torino

Tumbarello M; Trecarichi EM; Tumietto F; Del Bono V; De Rosa FG; Bassetti M; Losito AR; Tedeschi S; Saffioti C; Corcione S; Giannella M; Raffaelli F; Pagani N; Bartoletti M; Spanu T; Marchese A; Cauda R; Viscoli C; Viale P;

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19808. doi: 10.7448/IAS.17.4.19808. eCollection 2014.

2014
ASL Città di Torino

Fabbiani M; Di Giambenedetto S; Quiros-Roldan E; Latini A; Vullo V; Antinori A; Castagna A; Orofino G; Francisci D; Grilli E; Madeddu G; Grima P; Rusconi S; Del Pin B; Mondi A; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Mortality in patients with early- or late-onset candidaemia. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):927-35. doi: 10.1093/jac/dks480. Epub 2012 Dec 12.

2013
ASL Città di Torino

De Rosa FG; Trecarichi EM; Montrucchio C; Losito AR; Raviolo S; Posteraro B; Corcione S; Di Giambenedetto S; Fossati L; Sanguinetti M; Serra R; Cauda R; Di Perri G; Tumbarello M;